immune checkpoint inhibitor

You have access
Neck Dissection and Immune Checkpoint Inhibitor Efficacy in Head and Neck Cancer: A Retrospective Study
YOH-ICHIRO IWASA, KENTARO HORI, YOH YOKOTA, RYOSUKE KITOH, SHINTARO YAMAZAKI, TAKUYA OKUBO and YUTAKA TAKUMI

Anticancer Research February 2026, 46 (2) 1079-1087; DOI: https://doi.org/10.21873/anticanres.18010
You have access
Prognostic Factors in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
YUTAKA TAKAHARA, RYUDAI ABE, SUMITO NAGAE, TAKUYA TANAKA, YOKO ISHIGE, IKUYO SHIONOYA, KOUICHI YAMAMURA, MASAFUMI NOJIRI and MASAHARU IGUCHI

Anticancer Research December 2025, 45 (12) 5633-5644; DOI: https://doi.org/10.21873/anticanres.17897
You have access
Efficacy and Safety of Chemoimmunotherapy in Patients With Advanced Non-small Cell Lung Cancer With Pre-existing Interstitial Pneumonia and Low PD-L1 Expression
AOSA SASADA, HAYATO KAWACHI, TADAAKI YAMADA, TAE HATA, YASUHIRO GOTO, AKIHIKO AMANO, YOSHIKI NEGI, SATOSHI WATANABE, NAOKI FURUYA, TOMOHIRO OBA, TATSUKI IKOMA, AKIRA NAKAO, KEIKO TANIMURA, HIROKAZU TANIGUCHI, AKIHIRO YOSHIMURA, TOMOYA FUKUI, DAIKI MURATA, KYOICHI KAIRA, SHINSUKE SHIOTSU, ASUKA OKADA, YUSUKE CHIHARA, TAKASHI KIJIMA and KOICHI TAKAYAMA

Anticancer Research November 2025, 45 (11) 5045-5057; DOI: https://doi.org/10.21873/anticanres.17845
You have access
The Macrophage Activation Marker Soluble CD163 Predicts the Response to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma
SOICHI TAKEDA, TADASHI NAMISAKI, ARITOSHI KOIZUMI, HIROAKI TAKAYA, YUKI TSUJI, AKIHIKO SHIBAMOTO, SATOSHI IWAI, TAKASHI INOUE, YUKIHISA FUJINAGA, NORIHISA NISHIMURA, SHINYA SATO, KOH KITAGAWA, KOSUKE KAJI, AKIRA MITORO, KIYOSHI ASADA and HITOSHI YOSHIJI

Anticancer Research October 2025, 45 (10) 4493-4507; DOI: https://doi.org/10.21873/anticanres.17797
You have access
Thorough Lymphadenectomy Impairs Immunotherapy Outcomes for Postoperative Intrathoracic Recurrence of Non-small Cell Lung Cancer
MASAYA AOKI, GO KAMIMURA, YUSEI TSUNEYOSHI, SHOICHIRO MORIZONO, TAKUYA TOKUNAGA, AYA HARADA-TAKEDA, KOKI MAEDA, TOSHIYUKI NAGATA, KOTA KARIATSUMARI and KAZUHIRO UEDA

Anticancer Research September 2025, 45 (9) 3971-3981; DOI: https://doi.org/10.21873/anticanres.17755
You have access
Effect of Acid Suppressants on Adverse Events of Immune Checkpoint Inhibitors Using Real-world Databases
KEISUKE OKAMOTO, JURI TAKIZAWA, HINATA UEDA, KATSUYA NARUMI and MASAKI KOBAYASHI

Anticancer Research August 2025, 45 (8) 3287-3293; DOI: https://doi.org/10.21873/anticanres.17689
Open Access
Clinical Evaluation of Immune Cell Therapy in Esophageal Cancer Resistant to Immunochemotherapy
RISHU TAKIMOTO, TAKASHI KAMIGAKI, SACHIKO OKADA, HIROSHI IBE, ERI OGUMA, AYA OHNO and SHIGENORI GOTO

Anticancer Research August 2025, 45 (8) 3553-3559; DOI: https://doi.org/10.21873/anticanres.17716
You have access
Correlation Between Body Mass Index and Clinical Outcomes in Advanced Renal Cell Carcinoma Patients
KENSUKE BEKKU, SHOTA INOUE, KASUMI YOSHINAGA, YOSUKE MITSUI, TOMOAKI YAMANOI, TATSUSHI KAWADA, YUSUKE TOMINAGA, TAKUYA SADAHIRA, SATOSHI KATAYAMA, TAKEHIRO IWATA, SHINGO NISHIMURA, KOHEI EDAMURA, TOMOKO KOBAYASHI and MOTOO ARAKI

Anticancer Research June 2025, 45 (6) 2643-2651; DOI: https://doi.org/10.21873/anticanres.17635
Open Access
Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
NOBUKI FURUBAYASHI, MANABU MOCHIDA, ATSUHIRO KIJIMA, YUSHI FUJIMOTO, MOTONOBU NAKAMURA and TAKAHITO NEGISHI

Anticancer Research May 2025, 45 (5) 2185-2193; DOI: https://doi.org/10.21873/anticanres.17592
You have access
Recurrence Risk and Its Impact on Current Treatment Strategies in Early and Locally Advanced NSCLC
CHARLOTTE TEGENBOSCH and KAROLIEN VEKENS

Anticancer Research December 2024, 44 (12) 5495-5500; DOI: https://doi.org/10.21873/anticanres.17375

Main menu

User menu

Search

immune checkpoint inhibitor

Pages